-
Blockbuster drug with patent expiration in the next 10 years (12)-Disumab
Time of Update: 2021-09-04
In the absence of a large number of patent exclusivity losses in recent years, the company is expected to enter a growth phase driven by new drugs, including the migraine drug Aimovig (erenumab) and the newly approved anti-cancer drug Lumakras (sotorasib) .
-
With 100% potential to penetrate the blood-brain barrier
Time of Update: 2021-09-04
According to the latest announcement from the Center for Drug Evaluation (CDE) of the State Drug Administration of China, the first class of new drug zorifertinib tablets declared by Chentai Pharmaceutical has obtained the implied license for clinical trials, and it is planned to be developed for the treatment of non-small cell lung cancer (NSCLC) .
-
The State Food and Drug Administration issued 4 supplementary inspection announcements for proprietary Chinese medicines
Time of Update: 2021-09-04
Medical Network, August 24 News On August 23, the State Food and Drug Administration issued an announcement on two supplementary inspection methods including the supplementary inspection methods for
-
Well-known pharmaceutical companies responded: no layoffs
Time of Update: 2021-09-04
Mengdi China further stated that, judging from the feedback currently received by the company's human resources department, the overall feedback from employees who have been included in the talent retention program is positive-some of the previous information was not accurate .
-
Luoxin Pharmaceutical Appoints Han Feng as Secretary of the Board of Directors
Time of Update: 2021-09-04
On August 23, Luoxin Pharmaceutical issued an announcement stating that the company held the 16th meeting of the fourth board of directors today and reviewed and approved the "Proposal on Appointment of the Secretary of the Board of Directors .
-
China's CDE drug application status in July 2021
Time of Update: 2021-09-04
and the Institute of Basic Medicine, Chinese Academy of Medical Sciences conducted human phase I/IIA/IIB/III clinical trials in mainland China for the treatment of advanced non-small cell lung cancer .
launched a phase III clinical trial in mainland China for the treatment of non-small cell lung cancer .
-
In July, 136 product regulations passed the consistency evaluation of generic drugs
Time of Update: 2021-09-04
(Contributed by Yaorong Circle) According to data from the National Medical Products Administration on August 25th, in July this year, the Center for Drug Evaluation (CDE) of the National Medical Products Administration undertook 80 applications for the consistency evaluation of generic drugs (calculated by the acceptance number), and 54 varieties were accepted.
-
A number of studies show that the epidemic of the new coronavirus in Italy is earlier than Wuhan
Time of Update: 2021-09-03
the truth A heavier real hammer appeared a few months later-the study of "the molecular evidence that the new crown virus was prevalent in Lombardy, Italy in the late summer of 2019 in a rash sample" was sent to The Lancet earlier this month .
-
Children's intranasal cells will be "prepared" when "detecting" the new coronavirus
Time of Update: 2021-09-03
This different expression causes children to have a stronger early immune response to new coronavirus infections than adults .
-
Breast milk sugars help treat and prevent neonatal infections
Time of Update: 2021-09-03
Now, researchers have discovered that human milk oligosaccharides (HMOs), short-chain sugar molecules abundant in breast milk, help prevent GBS infections in human cells, tissues and mice .
-
North China Pharmaceutical responds to the situation and reasons why ibuprofen sustained-release capsules failed to be supplied as scheduled
Time of Update: 2021-09-03
(hereinafter referred to as the "Company") failed to supply the agreed procurement volume of ibuprofen sustained-release capsules in Shandong After collective deliberation by the member units of the Joint Procurement Office, it was decided to include the company on the "list of violations" and cancel the company's application qualification for participating in the centralized drug procurement activities organized by the state from August 11, 2021 to May 10, 2022 .
-
New antibodies can resist multiple new coronavirus variants
Time of Update: 2021-09-03
In order to find neutralizing antibodies that are effective against multiple mutations, the researchers first immunized mice with a key part of the spike protein called the receptor binding domain .
-
North China Pharmaceuticals proposed to abandon the qualification due to insufficient supply, and the joint procurement responds to the penalty decision
Time of Update: 2021-09-03
Regarding North China Pharmaceutical’s breach of contract, the United Procurement Office has stated in its announcement on August 20 that the company’s ibuprofen sustained-release capsules selected in the third batch of nationally organized drug procurement failed to supply the agreed procurement volume in Shandong Province according to the agreement.
-
Notice on Publicly Soliciting Opinions on "Technical Guidelines for Food Impact Research in the Process of New Drug Research and Development (Draft for Solicitation of Comments)"
Time of Update: 2021-09-03
pdf Annex 2: Drafting Instructions for "Technical Guidelines for Food Impact Research in the Process of New Drug Development (Draft for Solicitation of Comments)".
pdf Annex 3 : "Technical Guidelines for Food Impact Research in the Process of New Drug Development (Draft for Solicitation of Comments)" feedback form for soliciting opinions.
-
The new crown virus can spread through aerosols in the "handshake building"
Time of Update: 2021-09-03
In Ward 1, atomized fluorescent microspheres were used to simulate the breathing of the infected person, and the spread of the corridor at Site 2 and the room opposite to Site 3 was observed through the changes in the concentration of aerosol particles.
-
Zhong Nanshan: Over 80% of China's population can be herd immunity after being vaccinated
Time of Update: 2021-09-03
academician Zhong Nanshan said that research on the previous Guangzhou epidemic showed that the overall protection rate of the domestic inactivated vaccine against the Delta strain was close to 60%, and the critical illness protection rate was 100% .
-
More than 97% of people are susceptible to cancer. Healthy living can reduce the risk
Time of Update: 2021-09-03
"The study has constructed CPRS, which can quantify the overall genetic risk of cancer, and proves that almost everyone is at high risk of cancer, and a healthy lifestyle can reduce the overall risk of cancer .
-
British research: Two vaccines in use have a certain effect on the prevention of Delta strain
Time of Update: 2021-09-03
The results of the study show that both AstraZeneca vaccine and Pfizer vaccine can play a protective effect against the delta strain after two doses, but its protective effect is lower than that against the mutant new crown virus alpha strain.
-
Academician Zhang Boli: The epidemic makes more young people choose to study medicine
Time of Update: 2021-09-03
academician Zhang Boli said that the epidemic not only did not dampen the enthusiasm of the children, on the contrary, they were more eager to apply for medicine .
He warmly welcomes outstanding students to apply for the medical profession .
-
Can the Mid-Autumn Festival travel normally?
Time of Update: 2021-09-03
Zhang Boli responded to whether the Mid-Autumn Festival can travel normally?
Zhang Boli responded to whether the Mid-Autumn Festival can travel normally?
Zhang Boli responded Zhang Boli, an academician of the Chinese Academy of Engineering, said that now the rebound of the epidemic has improved significantly, and complete control is possible.
